Lancet子刊:“镰状细胞贫血”和“恶性疟原虫疟疾”之间的关系——对非洲儿童输血和治疗试验的二次分析

2022-07-24 liangying MedSci原创

即使在疟疾严重传播的情况下,SCA对高密度疟疾感染也具有一定程度的先天抵抗力,可防止由寄生虫引起的微循环障碍和器官衰竭。

在非洲,镰状细胞贫血(SCA)历来与儿童高死亡率有关,且疟疾是造成这一死亡率的主要原因。然而,迄今为止,关于SCA儿童中疟疾的临床病理学描述甚少。本研究的目的是通过调查在非洲进行的TRACT输血试验中招募的严重贫血儿童的疟疾感染负担和严重程度,进一步详细地探索SCA与恶性疟原虫疟疾之间的关系。

本研究是在试验完成后对TRACT试验数据进行的事后二次分析。TRACT是一项开放标签、多中心、析因、随机对照试验,将2个月至12岁患有严重贫血(血红蛋白<6.0g/dL)的儿童纳入非洲四家医院。该二级分析仅限于乌干达,那里的SCA出生流行率约为1%,疟疾传播率很高。儿童分为正常(HbAA)、杂合子(HbAS)、纯合子(HbSS;SCA)检测HBB rs334a→T镰状突变,并在试验结束时进行批量基因分型。

为了避免与SCA特异性医疗干预混淆,将已有SCA诊断(已知SCA)的儿童与试验结束时诊断的儿童(未知SCA)分开考虑。本次二次分析的结果是衡量疟疾阳性儿童的恶性疟原虫负担、严重疟疾特征和28天死亡率。

2014年9月17日至2017年5月15日,共3944名严重贫血儿童被纳入TRACT试验。本次二级分析考虑了3483名乌干达儿童。总的来说,1038名(30%)患有SCA。2321名无SCA(HbAA)的儿童中有1815名(78%)检测出恶性疟原虫阳性,而SCA儿童的患病率显著降低。

按镰刀基因型划分的疟疾阳性儿童28天死亡率

已知SCA或未知SCA儿童的血浆富含恶性组氨酸蛋白2(PfHRP2)浓度显著低于HbAA儿童,PfHRP2是个体内疟原虫总负担的标志。与HbAA儿童相比,少数HbSS儿童表现出严重和复杂疟疾的典型特征,但HbSS儿童贫血的频率和严重程度都较高。研究者发现,与无SCA的患者相比,有SCA的患者在第28天的死亡率总体上没有增加的证据。

总之,本研究表明即使在疟疾严重传播的情况下,SCA对高密度疟疾感染也具有一定程度的先天抵抗力,可防止由寄生虫引起的微循环障碍和器官衰竭。然而,研究还表明,即使是低密度恶性疟原虫感染也会引发血红蛋白的突然和灾难性下降,在没有紧急输血供应的情况下,这也可能会迅速导致死亡。

参考文献:Sickle cell anaemia and severe Plasmodium falciparum malaria: a secondary analysis of the Transfusion and Treatment of African Children Trial (TRACT). Sophie Uyoga, Prof Peter Olupot-Olupot, Roisin Connon, Prof Sarah Kiguli, MMed Robert O Opoka, MMed Florence Alaroker, MBChB et al. Published:July 01, 2022DOI:https://doi.org/10.1016/S2352-4642(22)00153-5

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1831619, encodeId=48871831619fb, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Mon Aug 01 00:00:21 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259751, encodeId=00711259e513b, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387883, encodeId=7511138e883c4, content=<a href='/topic/show?id=25ffe04313d' target=_blank style='color:#2F92EE;'>#疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70431, encryptionId=25ffe04313d, topicName=疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e622500011, createdName=12498484m46(暂无昵称), createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481195, encodeId=d1261481195f7, content=<a href='/topic/show?id=9546968e441' target=_blank style='color:#2F92EE;'>#镰状细胞贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96874, encryptionId=9546968e441, topicName=镰状细胞贫血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236a7745931, createdName=12498a1cm69暂无昵称, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578837, encodeId=284715e8837f3, content=<a href='/topic/show?id=9b395292257' target=_blank style='color:#2F92EE;'>#恶性疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52922, encryptionId=9b395292257, topicName=恶性疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b5f16444736, createdName=ms6832696159214430, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615552, encodeId=3883161555278, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96865, encryptionId=280196865f7, topicName=镰状细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb4819654385, createdName=1508842480_96220443, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234399, encodeId=29d51234399a9, content=👀, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:49:48 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234397, encodeId=b0f8123439e60, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:44:53 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1244057, encodeId=e558124405ebb, content=lancet上果然牛,感谢梅斯更新及时, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=younei, createdTime=Sat Jul 23 17:00:21 CST 2022, time=2022-07-23, status=1, ipAttribution=)]
    2022-08-01 docwu2019
  2. [GetPortalCommentsPageByObjectIdResponse(id=1831619, encodeId=48871831619fb, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Mon Aug 01 00:00:21 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259751, encodeId=00711259e513b, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387883, encodeId=7511138e883c4, content=<a href='/topic/show?id=25ffe04313d' target=_blank style='color:#2F92EE;'>#疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70431, encryptionId=25ffe04313d, topicName=疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e622500011, createdName=12498484m46(暂无昵称), createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481195, encodeId=d1261481195f7, content=<a href='/topic/show?id=9546968e441' target=_blank style='color:#2F92EE;'>#镰状细胞贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96874, encryptionId=9546968e441, topicName=镰状细胞贫血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236a7745931, createdName=12498a1cm69暂无昵称, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578837, encodeId=284715e8837f3, content=<a href='/topic/show?id=9b395292257' target=_blank style='color:#2F92EE;'>#恶性疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52922, encryptionId=9b395292257, topicName=恶性疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b5f16444736, createdName=ms6832696159214430, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615552, encodeId=3883161555278, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96865, encryptionId=280196865f7, topicName=镰状细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb4819654385, createdName=1508842480_96220443, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234399, encodeId=29d51234399a9, content=👀, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:49:48 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234397, encodeId=b0f8123439e60, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:44:53 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1244057, encodeId=e558124405ebb, content=lancet上果然牛,感谢梅斯更新及时, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=younei, createdTime=Sat Jul 23 17:00:21 CST 2022, time=2022-07-23, status=1, ipAttribution=)]
    2022-07-25 windight
  3. [GetPortalCommentsPageByObjectIdResponse(id=1831619, encodeId=48871831619fb, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Mon Aug 01 00:00:21 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259751, encodeId=00711259e513b, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387883, encodeId=7511138e883c4, content=<a href='/topic/show?id=25ffe04313d' target=_blank style='color:#2F92EE;'>#疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70431, encryptionId=25ffe04313d, topicName=疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e622500011, createdName=12498484m46(暂无昵称), createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481195, encodeId=d1261481195f7, content=<a href='/topic/show?id=9546968e441' target=_blank style='color:#2F92EE;'>#镰状细胞贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96874, encryptionId=9546968e441, topicName=镰状细胞贫血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236a7745931, createdName=12498a1cm69暂无昵称, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578837, encodeId=284715e8837f3, content=<a href='/topic/show?id=9b395292257' target=_blank style='color:#2F92EE;'>#恶性疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52922, encryptionId=9b395292257, topicName=恶性疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b5f16444736, createdName=ms6832696159214430, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615552, encodeId=3883161555278, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96865, encryptionId=280196865f7, topicName=镰状细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb4819654385, createdName=1508842480_96220443, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234399, encodeId=29d51234399a9, content=👀, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:49:48 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234397, encodeId=b0f8123439e60, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:44:53 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1244057, encodeId=e558124405ebb, content=lancet上果然牛,感谢梅斯更新及时, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=younei, createdTime=Sat Jul 23 17:00:21 CST 2022, time=2022-07-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1831619, encodeId=48871831619fb, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Mon Aug 01 00:00:21 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259751, encodeId=00711259e513b, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387883, encodeId=7511138e883c4, content=<a href='/topic/show?id=25ffe04313d' target=_blank style='color:#2F92EE;'>#疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70431, encryptionId=25ffe04313d, topicName=疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e622500011, createdName=12498484m46(暂无昵称), createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481195, encodeId=d1261481195f7, content=<a href='/topic/show?id=9546968e441' target=_blank style='color:#2F92EE;'>#镰状细胞贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96874, encryptionId=9546968e441, topicName=镰状细胞贫血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236a7745931, createdName=12498a1cm69暂无昵称, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578837, encodeId=284715e8837f3, content=<a href='/topic/show?id=9b395292257' target=_blank style='color:#2F92EE;'>#恶性疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52922, encryptionId=9b395292257, topicName=恶性疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b5f16444736, createdName=ms6832696159214430, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615552, encodeId=3883161555278, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96865, encryptionId=280196865f7, topicName=镰状细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb4819654385, createdName=1508842480_96220443, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234399, encodeId=29d51234399a9, content=👀, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:49:48 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234397, encodeId=b0f8123439e60, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:44:53 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1244057, encodeId=e558124405ebb, content=lancet上果然牛,感谢梅斯更新及时, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=younei, createdTime=Sat Jul 23 17:00:21 CST 2022, time=2022-07-23, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1831619, encodeId=48871831619fb, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Mon Aug 01 00:00:21 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259751, encodeId=00711259e513b, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387883, encodeId=7511138e883c4, content=<a href='/topic/show?id=25ffe04313d' target=_blank style='color:#2F92EE;'>#疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70431, encryptionId=25ffe04313d, topicName=疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e622500011, createdName=12498484m46(暂无昵称), createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481195, encodeId=d1261481195f7, content=<a href='/topic/show?id=9546968e441' target=_blank style='color:#2F92EE;'>#镰状细胞贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96874, encryptionId=9546968e441, topicName=镰状细胞贫血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236a7745931, createdName=12498a1cm69暂无昵称, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578837, encodeId=284715e8837f3, content=<a href='/topic/show?id=9b395292257' target=_blank style='color:#2F92EE;'>#恶性疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52922, encryptionId=9b395292257, topicName=恶性疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b5f16444736, createdName=ms6832696159214430, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615552, encodeId=3883161555278, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96865, encryptionId=280196865f7, topicName=镰状细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb4819654385, createdName=1508842480_96220443, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234399, encodeId=29d51234399a9, content=👀, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:49:48 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234397, encodeId=b0f8123439e60, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:44:53 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1244057, encodeId=e558124405ebb, content=lancet上果然牛,感谢梅斯更新及时, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=younei, createdTime=Sat Jul 23 17:00:21 CST 2022, time=2022-07-23, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1831619, encodeId=48871831619fb, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Mon Aug 01 00:00:21 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259751, encodeId=00711259e513b, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387883, encodeId=7511138e883c4, content=<a href='/topic/show?id=25ffe04313d' target=_blank style='color:#2F92EE;'>#疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70431, encryptionId=25ffe04313d, topicName=疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e622500011, createdName=12498484m46(暂无昵称), createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481195, encodeId=d1261481195f7, content=<a href='/topic/show?id=9546968e441' target=_blank style='color:#2F92EE;'>#镰状细胞贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96874, encryptionId=9546968e441, topicName=镰状细胞贫血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236a7745931, createdName=12498a1cm69暂无昵称, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578837, encodeId=284715e8837f3, content=<a href='/topic/show?id=9b395292257' target=_blank style='color:#2F92EE;'>#恶性疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52922, encryptionId=9b395292257, topicName=恶性疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b5f16444736, createdName=ms6832696159214430, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615552, encodeId=3883161555278, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96865, encryptionId=280196865f7, topicName=镰状细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb4819654385, createdName=1508842480_96220443, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234399, encodeId=29d51234399a9, content=👀, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:49:48 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234397, encodeId=b0f8123439e60, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:44:53 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1244057, encodeId=e558124405ebb, content=lancet上果然牛,感谢梅斯更新及时, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=younei, createdTime=Sat Jul 23 17:00:21 CST 2022, time=2022-07-23, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1831619, encodeId=48871831619fb, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Mon Aug 01 00:00:21 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259751, encodeId=00711259e513b, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387883, encodeId=7511138e883c4, content=<a href='/topic/show?id=25ffe04313d' target=_blank style='color:#2F92EE;'>#疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70431, encryptionId=25ffe04313d, topicName=疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e622500011, createdName=12498484m46(暂无昵称), createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481195, encodeId=d1261481195f7, content=<a href='/topic/show?id=9546968e441' target=_blank style='color:#2F92EE;'>#镰状细胞贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96874, encryptionId=9546968e441, topicName=镰状细胞贫血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236a7745931, createdName=12498a1cm69暂无昵称, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578837, encodeId=284715e8837f3, content=<a href='/topic/show?id=9b395292257' target=_blank style='color:#2F92EE;'>#恶性疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52922, encryptionId=9b395292257, topicName=恶性疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b5f16444736, createdName=ms6832696159214430, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615552, encodeId=3883161555278, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96865, encryptionId=280196865f7, topicName=镰状细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb4819654385, createdName=1508842480_96220443, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234399, encodeId=29d51234399a9, content=👀, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:49:48 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234397, encodeId=b0f8123439e60, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:44:53 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1244057, encodeId=e558124405ebb, content=lancet上果然牛,感谢梅斯更新及时, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=younei, createdTime=Sat Jul 23 17:00:21 CST 2022, time=2022-07-23, status=1, ipAttribution=)]
    2022-07-24 ms7000000004042513

    👀

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1831619, encodeId=48871831619fb, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Mon Aug 01 00:00:21 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259751, encodeId=00711259e513b, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387883, encodeId=7511138e883c4, content=<a href='/topic/show?id=25ffe04313d' target=_blank style='color:#2F92EE;'>#疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70431, encryptionId=25ffe04313d, topicName=疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e622500011, createdName=12498484m46(暂无昵称), createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481195, encodeId=d1261481195f7, content=<a href='/topic/show?id=9546968e441' target=_blank style='color:#2F92EE;'>#镰状细胞贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96874, encryptionId=9546968e441, topicName=镰状细胞贫血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236a7745931, createdName=12498a1cm69暂无昵称, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578837, encodeId=284715e8837f3, content=<a href='/topic/show?id=9b395292257' target=_blank style='color:#2F92EE;'>#恶性疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52922, encryptionId=9b395292257, topicName=恶性疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b5f16444736, createdName=ms6832696159214430, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615552, encodeId=3883161555278, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96865, encryptionId=280196865f7, topicName=镰状细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb4819654385, createdName=1508842480_96220443, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234399, encodeId=29d51234399a9, content=👀, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:49:48 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234397, encodeId=b0f8123439e60, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:44:53 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1244057, encodeId=e558124405ebb, content=lancet上果然牛,感谢梅斯更新及时, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=younei, createdTime=Sat Jul 23 17:00:21 CST 2022, time=2022-07-23, status=1, ipAttribution=)]
    2022-07-24 ms7000000004042513

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1831619, encodeId=48871831619fb, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Mon Aug 01 00:00:21 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259751, encodeId=00711259e513b, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387883, encodeId=7511138e883c4, content=<a href='/topic/show?id=25ffe04313d' target=_blank style='color:#2F92EE;'>#疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70431, encryptionId=25ffe04313d, topicName=疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e622500011, createdName=12498484m46(暂无昵称), createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481195, encodeId=d1261481195f7, content=<a href='/topic/show?id=9546968e441' target=_blank style='color:#2F92EE;'>#镰状细胞贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96874, encryptionId=9546968e441, topicName=镰状细胞贫血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236a7745931, createdName=12498a1cm69暂无昵称, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578837, encodeId=284715e8837f3, content=<a href='/topic/show?id=9b395292257' target=_blank style='color:#2F92EE;'>#恶性疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52922, encryptionId=9b395292257, topicName=恶性疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b5f16444736, createdName=ms6832696159214430, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615552, encodeId=3883161555278, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96865, encryptionId=280196865f7, topicName=镰状细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb4819654385, createdName=1508842480_96220443, createdTime=Mon Jul 25 05:00:21 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234399, encodeId=29d51234399a9, content=👀, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:49:48 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234397, encodeId=b0f8123439e60, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:44:53 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1244057, encodeId=e558124405ebb, content=lancet上果然牛,感谢梅斯更新及时, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=younei, createdTime=Sat Jul 23 17:00:21 CST 2022, time=2022-07-23, status=1, ipAttribution=)]
    2022-07-23 younei

    lancet上果然牛,感谢梅斯更新及时

    0

相关资讯

J Clin Periodontol:镰状细胞贫血患者的铁过载及牙周状况

本文旨在研究镰状细胞贫血(SCA)患者的铁过载、牙周状况和牙周炎程度的相关性。

NEJM:镰状细胞贫血羟基脲治疗剂量差异研究

对于撒哈拉以南非洲镰状细胞贫血儿童,升高剂量羟基脲治疗方案的临床效果优于固定剂量方案

NEJM:羟基脲用于撒哈拉以南非洲国家儿童镰状细胞贫血

研究认为,羟基脲用于撒哈拉以南非洲国家儿童镰状细胞贫血的治疗是可行的。

JAMA:静脉注射泊洛沙姆188对镰状细胞贫血患者疼痛性血管闭塞发作持续时间的影响

镰状细胞贫血(SCD)是一种常染色体显性遗传血红蛋白病,其特征是血管闭塞危象和急性疼痛。目前FDA批准了3种药物用于预防血管闭塞发作,分别为羟基脲、L-谷氨酰胺和crizanlizumab-tmca,

N Engl J Med :首次!CRISPR-Cas9技术可在人体实验中有效治疗镰状细胞贫血和β-地中海贫血

镰刀型红细胞贫血(SCD)和β-地中海贫血(TDT)是两种常见的基因缺陷性疾病,其共同特点是由于珠蛋白基因的缺陷使血红蛋白中的珠蛋白肽链有一种或几种合成减少或不能合成,从而产生无效的血红蛋白。

欧洲药品管理局(EMA)开始审查GBT的镰状细胞疗法Oxbryta

Oxbryta(voxelotor)旨在治疗12岁及以上的镰状细胞病(SCD)患者的溶血性贫血。